Related Experiment Video
Updated: May 24, 2026
Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
Published on: August 29, 2016
Breaking through a roadblock in prostate cancer research: an update on human model systems
R Toivanen1, R A Taylor, D W Pook
1Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria 3800, Australia.
Abstract:
Prostate cancer is a prevalent disease that affects the aging male population. Whilst there have been significant advances of our biological understanding of the disease, clinical translation of promising agents continues to lag behind. In part, this is due to a paucity of relevant experimental and pre-clinical models required to further develop effective prevention and therapeutic strategies. Genetically modified cell lines fail to entirely represent the genetic and molecular diversity of primary human specimens, particularly from localised disease. Furthermore, primary prostate cancer tissues are extremely difficult to grow in the laboratory and virtually all human models, whether they grow as xenografts in immune-deficient animals or as cell cultures, are genetically modified by the investigator or derived from patients with advanced metastatic disease. In this review, we discuss the latest advances and improvements to current methods of xenografting human primary prostate cancer, and their potential application to translational research.
Insights
Developing better prostate cancer models is crucial for advancing treatments. This review explores improved xenografting techniques for primary prostate cancer, aiding translational research and drug development.
Area of Science:
- Oncology
- Translational Research
- Pre-clinical Models
Background:
- Prostate cancer significantly impacts aging men, with clinical translation of therapies lagging.
- Existing pre-clinical models, like cell lines and xenografts, inadequately represent primary prostate cancer's diversity.
- Primary prostate cancer tissues are challenging to cultivate in laboratory settings.
Purpose of the Study:
- To review recent advancements in xenografting primary human prostate cancer.
- To discuss the potential of these improved models for translational research.
Main Methods:
- Discussion of current xenografting techniques for primary prostate cancer.
- Analysis of improvements in xenograft model development.
Main Results:
- Identified limitations in current genetically modified cell lines and xenografts.
- Highlighted challenges in culturing primary prostate cancer tissues.
- Presented recent improvements in xenografting human primary prostate cancer.
Conclusions:
- Improved xenograft models are essential for effective prostate cancer prevention and therapy development.
- Enhanced xenografting methods offer potential for advancing translational research in prostate cancer.
- Further development of these models is critical for bridging the gap between biological understanding and clinical application.
